Clinical Trial Update: The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating polyene phosphatidylcholine for liver injury after liver resection; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Disease

Drugs mentioned

• Polyene phosphatidylcholine (polyene phosphatidylcholine)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Hepatocellular Carcinoma (HCC), Liver Diseases | Phase 4 | Status: RECRUITING